Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
terpene-enriched cannabidiol oil
- Development stage
- Unknown
- Lead developer
- Bazelet Nehushtan
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A terpene-enriched cannabidiol (CBD) oil formulation developed by Bazelet Nehushtan Ltd. for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents. The product is a non-psychoactive cannabinoid formulation derived from the cannabis plant, specifically enriched with terpenes and devoid of THC to avoid psychoactive side effects. It is designed to modulate the endocannabinoid system, which is involved in cognitive function, motor coordination, and emotional regulation, and may influence dopaminergic pathways implicated in ADHD. The drug is currently being evaluated in Phase 2 clinical trials as a potential alternative for patients who do not respond well to conventional stimulant treatments like methylphenidate or amphetamines.
- Other names
- CBD oil enriched with terpenesBazelet CBD oilOral CBD oil enriched with terpenes
02
Targets
ADRA1A (α1A)HTR2A (Serotonin receptor 5-HT2A)TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPV2 (Transient receptor potential cation channel subfamily V member 2)CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GPR55 (G protein-coupled receptor 55)HTR3A (5-hydroxytryptamine receptor 3A)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on terpene-enriched cannabidiol oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on terpene-enriched cannabidiol oil.